Chimerix, Inc.
USD8.54
+0.00 (+0.00%)
CEO
Michael T. Andriole
IPO Date
2013-04-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.54
Prev. Close
$8.54
Day Low
$8.54
Day High
$8.54
52W Low
$0.75
52W High
$8.55
Market Cap
$0.80B
Volume
2.55M
| -1.0 |
| 31 Dec 2022 | FY | 98.7% | 509.0% | 67.0% | 61.6% | 0.01 | 11.18 | 0.9 |
| 31 Dec 2021 | FY | 76.4% | -12925.5% | -374.8% | -254.4% | 0.24 | 3.20 | -2.1 |
| 31 Dec 2020 | FY | -574.5% | -784.2% | -57.4% | -49.7% | 0.04 | 9.57 | -7.1 |
| 31 Dec 2019 | FY | -207.5% | -1387.1% | -157.9% | -145.5% | 0.00 | 12.80 | -0.6 |
| 31 Dec 2018 | FY | -665.5% | -962.8% | -39.1% | -36.4% | 0.00 | 14.61 | -1.8 |
| 31 Dec 2017 | FY | -1000.3% | -1579.5% | -32.0% | -30.2% | 0.00 | 11.86 | -3.1 |
| 31 Dec 2016 | FY | -928.5% | -1339.7% | -27.7% | -26.6% | 0.00 | 23.40 | -2.8 |
| 31 Dec 2015 | FY | -808.0% | -1090.6% | -35.0% | -33.0% | 0.00 | 11.34 | -3.3 |
| -0.9 |
| 30 Jun 2024 | Q2 | 100.0% | -16034.9% | -13.3% | -11.6% | 0.01 | 6.94 | -0.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -12.6% | -11.3% | 0.01 | 8.61 | -1.1 |
| 31 Dec 2023 | Q4 | -531475.0% | -454025.0% | -9.4% | -8.5% | 0.01 | 10.25 | -1.2 |
| 30 Sept 2023 | Q3 | -142236.4% | -218054.5% | -11.5% | -10.6% | 0.01 | 12.94 | -0.9 |
| 30 Jun 2023 | Q2 | -65000.0% | -71446.2% | -8.3% | -7.7% | 0.01 | 13.79 | -1.4 |
| 31 Mar 2023 | Q1 | 99.3% | -6546.3% | -7.7% | -7.2% | 0.01 | 13.68 | -1.5 |
| 31 Dec 2022 | Q4 | 99.3% | -2574.9% | -8.2% | -7.5% | 0.01 | 11.18 | -2.0 |
| 30 Sept 2022 | Q3 | 99.0% | 741.4% | 88.1% | 82.1% | 0.01 | 16.44 | 0.2 |